We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+18.19%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$691M
AUM Growth
+$12.7M
Cap. Flow
-$48.1M
Cap. Flow %
-6.95%
Top 10 Hldgs %
22.09%
Holding
156
New
27
Increased
26
Reduced
63
Closed
40

Top Sells

Rank Stock Value
1
CVLT icon
Commault Systems
CVLT
+$11.7M
2
VRNS icon
Varonis Systems
VRNS
+$11M
3
SPT icon
Sprout Social
SPT
+$9.61M
4
CROX icon
Crocs
CROX
+$9.4M
5
ACHC icon
Acadia Healthcare
ACHC
+$8.68M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Industrials 22.71%
3 Healthcare 20.87%
4 Consumer Discretionary 15.31%
5 Financials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOOT icon
1
Boot Barn
BOOT
$4.51B
$21.8M 3.15%
176,778
-2,320
-1% -$262K
SITM icon
2
SiTime
SITM
$16B
$18.9M 2.73%
64,615
+6,195
+11% +$1.62M
KRNT icon
3
Kornit Digital
KRNT
$705M
$16.9M 2.45%
111,173
-1,320
-1% -$203K
MXL icon
4
MaxLinear
MXL
$6.06B
$16.2M 2.34%
214,305
+70,600
+49% +$4.52M
INSP icon
5
Inspire Medical Systems
INSP
$1.45B
$15.9M 2.3%
69,085
+39,360
+132% +$9.61M
LSCC icon
6
Lattice Semiconductor
LSCC
$17.6B
$14.1M 2.04%
183,340
+30,585
+20% +$2.27M
SAIA icon
7
Saia
SAIA
$9.27B
$13.9M 2.01%
+41,140
New +$12.8M
KNX icon
8
Knight Transportation
KNX
$11.3B
$12.1M 1.75%
+197,915
New +$11.2M
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$11.6M 1.68%
84,170
-1,110
-1% -$141K
TNDM icon
10
Tandem Diabetes Care
TNDM
$1.34B
$11.4M 1.64%
75,500
+22,600
+43% +$3.05M
SYNA icon
11
Synaptics
SYNA
$4.19B
$11.2M 1.62%
38,730
-185
-0.5% -$44.2K
BLD
12
DELISTED
TopBuild
BLD
$11.2M 1.62%
40,495
-580
-1% -$148K
SUM
13
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$11M 1.6%
279,416
+109,236
+64% +$4M
RPD icon
14
Rapid7
RPD
$645M
$10.8M 1.56%
91,660
+6,040
+7% +$745K
CALX icon
15
Calix
CALX
$2.26B
$10.7M 1.54%
133,480
-640
-0.5% -$41.8K
CYTK icon
16
Cytokinetics
CYTK
$10.5B
$9.98M 1.44%
+218,860
New +$8.44M
VCRA
17
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$9.95M 1.44%
153,460
+26,930
+21% +$1.51M
ONT
18
Onterris Inc
ONT
$759M
$9.8M 1.42%
138,954
-1,695
-1% -$117K
RRR icon
19
Red Rock Resorts
RRR
$3.77B
$9.38M 1.36%
170,430
+52,760
+45% +$2.74M
ARCB icon
20
ArcBest
ARCB
$3.23B
$9.16M 1.33%
+76,410
New +$7.78M
SUPN icon
21
Supernus Pharmaceuticals
SUPN
$2.59B
$8.88M 1.28%
+304,455
New +$9.24M
EXTR icon
22
Extreme Networks
EXTR
$3.94B
$8.49M 1.23%
540,865
+172,780
+47% +$2.12M
CCXI
23
DELISTED
ChemoCentryx, Inc.
CCXI
$8.41M 1.22%
+231,035
New +$8.11M
GTLS
24
DELISTED
Chart Industries
GTLS
$8.21M 1.19%
51,452
-36,300
-41% -$6.42M
WMS icon
25
Advanced Drainage Systems
WMS
$10.6B
$8.19M 1.19%
60,178
-10,595
-15% -$1.3M

Similar funds

Lisanti Capital Growth's Q4 2021 Portfolio in Review

As of Q4 2021, Lisanti Capital Growth held 156 positions worth $691M, up 1.9% from $678M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Lisanti Capital Growth withdrew a net $48.1M in Q4 2021, closing 40 positions and reducing 63 holdings. Its most notable exit was Commault Systems, an estimated $11.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Saia worth $13.9M.

  • Lisanti Capital Growth's largest Q4 2021 buy was Saia: 41,140 shares worth $13.9M.
  • Lisanti Capital Growth added most to Inspire Medical Systems in Q4 2021, an estimated $9.61M increase.
  • Lisanti Capital Growth's biggest Q4 2021 reduction was Sprout Social, cutting an estimated $9.61M.
  • Lisanti Capital Growth fully exited Commault Systems in Q4 2021, selling an estimated $11.7M.
  • Lisanti Capital Growth's ten largest holdings make up 22% of its $691M portfolio in Q4 2021.
  • Lisanti Capital Growth opened 27 new positions and closed 40 in Q4 2021.
  • Lisanti Capital Growth's portfolio value rose 1.9% quarter-over-quarter to $691M.

Based on Lisanti Capital Growth's 13F filing for Q4 2021, filed 4 Feb 2022.